David Roalf

Imaging brain glutamate at ultra‑high field.

I'm a cognitive neuroscientist at the University of Pennsylvania. My lab uses 7 Tesla MRI, especially glutamate‑weighted CEST (GluCEST), to measure excitatory–inhibitory balance across the lifespan and across psychiatric and neurological conditions.

  • Research Associate Professor of Psychiatry, Perelman School of Medicine
  • Brain Behavior Laboratory · Neurodevelopment & Psychosis Section
  • Associate Fellow, Penn Institute on Aging · Lifespan Brain Institute · Neuroscience Graduate Group
+3 0 −3 Δω (ppm) 1.0 0 S/S₀ GluCEST (amine –NH₂) water
Z‑spectrum schematic. Glutamate amine protons exchange with water at ≈3 ppm; the asymmetry there is the GluCEST signal. 7T · B₀ ≈ 300 MHz.

Research

7T · GluCEST · E/I balance

Measuring glutamate in the living human brain

Developing and validating glutamate‑weighted CEST at 7 Tesla: reproducibility, B₁ correction, relationships to receptor density, and the open‑source pyGluCEST processing pipeline.

Psychosis spectrum · 22q11.2 deletion

Neurodevelopmental risk for psychosis

Glutamate, white‑matter microstructure, and craniofacial and midline brain markers in youth at risk for psychosis and in 22q11.2 deletion syndrome. Infrastructure roles on AMP‑SCZ ProNET.

Aging · Alzheimer's · Parkinson's

Early markers of cognitive decline

Hippocampal glutamate in healthy aging, olfactory screening for incipient Alzheimer's disease, within‑individual variability, and brief cognitive screens including the short‑form MoCA.

Cannabis · Epilepsy · MS · Depression

Glutamate across conditions

Collaborative 7T studies of cannabis use in psychosis, drug‑resistant epilepsy, multiple sclerosis, and treatment response in depression, asking whether E/I imbalance is a shared mechanism.

Selected publications 168 peer‑reviewed · full list on PubMed

Software & tools

Python · 7T GluCEST

pyGluCEST

Open‑source pipeline for processing glutamate‑weighted CEST data: B₀/B₁ correction, contrast calculation, and atlas‑space output. See the ISMRM 2022 abstract on building a robust, reproducible GluCEST pipeline.

ISMRM abstract →
Neuropsychology · cognitive screening

MoCA short form & MMSE ↔ MoCA crosswalk

Conversion tables between the MMSE and MoCA for Alzheimer's disease (Roalf et al., Alzheimer's & Dementia 2013) and Parkinson's disease (van Steenoven et al., Movement Disorders 2014), and the short‑form MoCA (Roalf et al., JNNP 2016).

MMSE↔MoCA paper →

Teaching & mentoring

Faculty Co‑Director, Penn Neuroscience Graduate Group Systems Neuroscience core (2024–). Lecturer for PGY2 psychiatry residents on neuroimaging in psychiatry and the neurobiology of aging and cognition.

Member of the NGG Admissions and Academic Review committees; program committee for the Society of Biological Psychiatry annual meeting.

Trainees. Primary supervisor for MD/PhD and NGG students, and faculty mentor to a long line of post‑bac research coordinators and summer scholars, many of whom have gone on to graduate and medical training. If you're interested in 7T imaging, glutamate, or psychosis‑risk research, get in touch.

Curriculum vitae

Ph.D.
Behavioral Neuroscience, Oregon Health & Science University, 2010
B.S.
Biological Psychology, The College of William & Mary, 2001
Postdoc
NIH T32 Neuropsychiatry Fellowship, University of Pennsylvania, 2010–2013
Faculty
Research Associate Professor of Psychiatry, 2025– · Research Assistant Professor, 2015–2025

Full CV (appointments, funding, service, 168 peer‑reviewed publications), updated August 2026.

Download CV (PDF) →

Contact

Email
roalf@upenn.edu
Office
Brain Behavior Laboratory, Richards Building, 3700 Hamilton Walk, 5th Floor Pod A, Room 5002, Philadelphia, PA 19104
Penn
Faculty profile →